Saint-Petersburg experience of allogeneic hematopoietic stem cell transplantation in patients with acute leukemia and human immunodeficiency virus

cttjournal.com 24 CTT JOURNAL | VOLUME 4 | NUMBER 1-2 | AUGUST 2015 Marina Popova, MD, Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation, First St. Petersburg State I. Pavlov Medical University, L. Tolstoy St 6-8, 197022, St. Petersburg, Russia Phone: +7-812-233-29-25 (office); +7-911-711-39-77 (mobile) E-mail: marina.popova.spb@gmail.com Boris V. Afanasyev1, Marina Popova1, Sergey Bondarenko1, Ilya Zyuzgin2, Elena Babenko1, Aleksander Alyanskiy1, Susanne Morsch3, Jan van Lunzen4, Boris Fehse5, Axel R. Zander 5, Ludmila S. Zubarovskaya1

[1]  A. Gennery,et al.  Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants , 2015, Bone Marrow Transplantation.

[2]  D. Elashoff,et al.  RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice , 2015, Molecular therapy. Nucleic acids.

[3]  Emily B Hanhauser,et al.  Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation , 2014, Annals of Internal Medicine.

[4]  S. Choi,et al.  Current and emerging strategies for the prevention of graft-versus-host disease , 2014, Nature Reviews Clinical Oncology.

[5]  S. Forman,et al.  Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: considerations for evidence-based GVHD prophylaxis , 2014, Expert review of hematology.

[6]  A. Gennery,et al.  Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation , 2014, Bone Marrow Transplantation.

[7]  Wei-Ting Hwang,et al.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. , 2014, The New England journal of medicine.

[8]  R. Doms,et al.  Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. , 2014, Blood.

[9]  S. Kitchen,et al.  Stem-Cell-Based Gene Therapy for HIV Infection , 2013, Viruses.

[10]  L. Petz.  Cord Blood Transplantation for Cure of HIV Infections , 2013, Stem cells translational medicine.

[11]  A. LaCasce,et al.  Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. , 2013, The Journal of infectious diseases.

[12]  R. Mitsuyasu.  Curing HIV: lessons from cancer therapy , 2013, Current opinion in HIV and AIDS.

[13]  R. Siliciano,et al.  Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient , 2013, PLoS pathogens.

[14]  J. Eron,et al.  Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy , 2012, Nature.

[15]  J. Hoxie,et al.  Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. , 2012, The New England journal of medicine.

[16]  Hans-Peter Kiem,et al.  Hematopoietic-stem-cell-based gene therapy for HIV disease. , 2012, Cell stem cell.

[17]  S. Steinberg,et al.  Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. , 2011, Blood.

[18]  G. Hütter,et al.  Eradication of HIV by Transplantation of CCR5-Deficient Hematopoietic Stem Cells , 2011, TheScientificWorldJournal.

[19]  J. Zaia,et al.  Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years , 2011, Clinical and experimental immunology.

[20]  J. Hauber,et al.  Gene Therapy Strategies: Can We Eradicate HIV? , 2011, Current HIV/AIDS reports.

[21]  E. Thiel,et al.  Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2. , 2011, AIDS.

[22]  A. Krishnan,et al.  HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL). , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  E. Thiel,et al.  Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. , 2009, The New England journal of medicine.

[24]  H. Atkins,et al.  Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[25]  Arsène Burny,et al.  Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection , 2009, PloS one.

[26]  N. Schmitz,et al.  Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. , 2009, Blood.

[27]  Felix Hermann,et al.  Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  G. Griffiths,et al.  Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody , 2006, AIDS.

[29]  J. Goedert,et al.  Trends in cancer risk among people with AIDS in the United States 1980–2002 , 2006, AIDS.

[30]  Thierry Daniel Tamsir Nesseim,et al.  Regular Articles , 2005, Plant and Soil.

[31]  H. Radtke,et al.  The BFM-protocol for HIV-negative Burkitt's lymphomas and L3 ALL in adult patients: a high chance for cure , 1992, Annals of Hematology.

[32]  Xianghui Yu,et al.  Influence of Primate Lentiviral Vif and Proteasome Inhibitors on Human Immunodeficiency Virus Type 1 Virion Packaging of APOBEC3G , 2004, Journal of Virology.

[33]  M. McBride,et al.  Acute B cell lymphoblastic leukaemia and human immunodeficiency virus infection (HIV). , 2002, The Ulster medical journal.

[34]  B. Dezube,et al.  Acute myeloid leukemia in patients infected with HIV-1 , 2002, AIDS.

[35]  P. Guénel,et al.  Acute myeloid leukaemia in human immunodeficiency virus‐infected adults: epidemiology, treatment feasibility and outcome , 2001, British journal of haematology.

[36]  S. Franceschi,et al.  Epidemiology of HIV-associated malignancies. , 2001, Cancer treatment and research.

[37]  D. Kane,et al.  The management of acute myeloid leukaemia (AML) in human immunodeficiency virus (HIV) infection: a case report and review , 1997, International journal of STD & AIDS.

[38]  O. Ramilo,et al.  The use of cyclosporine , FK506 and SDZ NIM 811 to prevent CD25 quiescent peripheral blood mononuclear cells from producing HIV-1 , 1996 .

[39]  B. Dhabhar,et al.  Human immunodeficiency virus (HIV) infection associated with acute myeloblastic leukemia in a low HIV prevalence area. , 1994, Acta haematologica.

[40]  C. Farber,et al.  Chemotherapy of acute myeloblastic leukemia in an HIV carrier , 1993, European journal of haematology.

[41]  M. Turner,et al.  An HIV positive haemophiliac with acute lymphoblastic leukaemia successfully treated with intensive chemotherapy and syngeneic bone marrow transplantation. , 1992, Bone marrow transplantation.

[42]  A. Postel,et al.  Acute monocytic leukaemia in a HIV‐seropositive man , 1992, Clinical and experimental dermatology.